Cargando…

The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease

OBJECTIVE: Alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD. METHODS: We conducted a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Jiajun, Kuang, Maobin, Yang, Ruijuan, Yu, Changhui, He, Shiming, Sheng, Guotai, Zou, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505795/
https://www.ncbi.nlm.nih.gov/pubmed/37727457
http://dx.doi.org/10.3389/fendo.2023.1239398
_version_ 1785106980913807360
author Qiu, Jiajun
Kuang, Maobin
Yang, Ruijuan
Yu, Changhui
He, Shiming
Sheng, Guotai
Zou, Yang
author_facet Qiu, Jiajun
Kuang, Maobin
Yang, Ruijuan
Yu, Changhui
He, Shiming
Sheng, Guotai
Zou, Yang
author_sort Qiu, Jiajun
collection PubMed
description OBJECTIVE: Alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD. METHODS: We conducted a retrospective analysis of data from 14,251 individuals participating in the NAGALA project’s health screening program. The presence of NAFLD was diagnosed based on the participants’ alcohol consumption status and liver ultrasonography images. Multivariable logistic regression models were used to assess the association between the ALT/HDL-C ratio and NAFLD. Receiver operating characteristic (ROC) analysis was performed to determine and compare the effectiveness of ALT, HDL-C, the aspartate aminotransferase to HDL-C (AST/HDL-C) ratio, the gamma-glutamyl transferase to HDL-C (GGT/HDL-C) ratio and the ALT/HDL-C ratio in identifying NAFLD. RESULTS: We observed a significant positive association between the ALT/HDL-C ratio and the prevalence of NAFLD. For each standard deviation (SD) increase in the ALT/HDL-C ratio, the adjusted odds ratio (OR) for NAFLD among the participants was 3.05 [95% confidence interval (CI): 2.63, 3.53], with the highest quartile of ALT/HDL-C ratio having a 9.96-fold increased risk compared to the lowest quartile. In further subgroup analyses stratified by gender, age, and waist circumference (WC), we observed a significantly higher risk of NAFLD associated with the ALT/HDL-C ratio among individuals aged ≥45 years, males, and those who were abdominal obesity. Furthermore, based on the results of ROC analysis, we found that the ALT/HDL-C ratio [area under the curves (AUC): 0.8553] was significantly superior to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio in identifying NAFLD (All Delong P<0.05); the threshold of suggested ALT/HDL-C ratio for identifying NAFLD was 15.97. CONCLUSION: This population-based study demonstrates a positive association between the ALT/HDL-C ratio and NAFLD. The ALT/HDL-C ratio can effectively identify individuals with NAFLD.
format Online
Article
Text
id pubmed-10505795
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105057952023-09-19 The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease Qiu, Jiajun Kuang, Maobin Yang, Ruijuan Yu, Changhui He, Shiming Sheng, Guotai Zou, Yang Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Alanine aminotransferase (ALT) and high-density lipoprotein cholesterol (HDL-C) are important predictive factors for non-alcoholic fatty liver disease (NAFLD). The aim of this study was to analyze the association between the ALT/HDL-C ratio and NAFLD. METHODS: We conducted a retrospective analysis of data from 14,251 individuals participating in the NAGALA project’s health screening program. The presence of NAFLD was diagnosed based on the participants’ alcohol consumption status and liver ultrasonography images. Multivariable logistic regression models were used to assess the association between the ALT/HDL-C ratio and NAFLD. Receiver operating characteristic (ROC) analysis was performed to determine and compare the effectiveness of ALT, HDL-C, the aspartate aminotransferase to HDL-C (AST/HDL-C) ratio, the gamma-glutamyl transferase to HDL-C (GGT/HDL-C) ratio and the ALT/HDL-C ratio in identifying NAFLD. RESULTS: We observed a significant positive association between the ALT/HDL-C ratio and the prevalence of NAFLD. For each standard deviation (SD) increase in the ALT/HDL-C ratio, the adjusted odds ratio (OR) for NAFLD among the participants was 3.05 [95% confidence interval (CI): 2.63, 3.53], with the highest quartile of ALT/HDL-C ratio having a 9.96-fold increased risk compared to the lowest quartile. In further subgroup analyses stratified by gender, age, and waist circumference (WC), we observed a significantly higher risk of NAFLD associated with the ALT/HDL-C ratio among individuals aged ≥45 years, males, and those who were abdominal obesity. Furthermore, based on the results of ROC analysis, we found that the ALT/HDL-C ratio [area under the curves (AUC): 0.8553] was significantly superior to ALT, HDL-C, AST/HDL-C ratio and GGT/HDL-C ratio in identifying NAFLD (All Delong P<0.05); the threshold of suggested ALT/HDL-C ratio for identifying NAFLD was 15.97. CONCLUSION: This population-based study demonstrates a positive association between the ALT/HDL-C ratio and NAFLD. The ALT/HDL-C ratio can effectively identify individuals with NAFLD. Frontiers Media S.A. 2023-08-31 /pmc/articles/PMC10505795/ /pubmed/37727457 http://dx.doi.org/10.3389/fendo.2023.1239398 Text en Copyright © 2023 Qiu, Kuang, Yang, Yu, He, Sheng and Zou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Qiu, Jiajun
Kuang, Maobin
Yang, Ruijuan
Yu, Changhui
He, Shiming
Sheng, Guotai
Zou, Yang
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
title The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
title_full The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
title_fullStr The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
title_full_unstemmed The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
title_short The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
title_sort newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505795/
https://www.ncbi.nlm.nih.gov/pubmed/37727457
http://dx.doi.org/10.3389/fendo.2023.1239398
work_keys_str_mv AT qiujiajun thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT kuangmaobin thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT yangruijuan thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT yuchanghui thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT heshiming thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT shengguotai thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT zouyang thenewlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT qiujiajun newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT kuangmaobin newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT yangruijuan newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT yuchanghui newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT heshiming newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT shengguotai newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease
AT zouyang newlyproposedalanineaminotransferasetohighdensitylipoproteincholesterolratiohasshowneffectivenessinidentifyingnonalcoholicfattyliverdisease